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The functions of Src family kinases are tightly regulated through Src homology (SH) domain-
mediated protein–protein interactions. We previously reported the biophysical characteristics of
the apoptosis-linked gene 2-interacting protein X (Alix) in complex with the haemopoietic cell
kinase (Hck) SH3 domain. In the current study, we have combined ITC, NMR, SAXS and molecular
modeling to determine a 3D model of the complex. We demonstrate that Hck SH3 recognizes an
extended linear proline-rich region of Alix. This particular binding mode enables Hck SH3 to sense
a speciﬁc non-canonical residue situated in the SH3 RT-loop of the kinase. The resulting model helps
clarify the mechanistic insights of Alix–Hck interaction.
Structured summary of protein interactions:
Hck physically interacts with SAM68 by two hybrid (View interaction)
FynR96I physically interacts with Alix by two hybrid (View interaction)
Hck binds to Alix by pull down (View interaction)
Fyn physically interacts with SAM68 by two hybrid (View interaction)
Hck and Alix bind by nuclear magnetic resonance (View interaction)
FynR96I and Alix bind by isothermal titration calorimetry (View Interaction: 1, 2)
FynR96I and Alix bind by nuclear magnetic resonance (View interaction)
FynR96I binds to Alix by pull down (View interaction)
Hck physically interacts with Alix by two hybrid (View interaction)
FynR96I and Alix bind by x ray scattering (View interaction)
Hck physically interacts with NEF by two hybrid (View interaction)
FynR96I physically interacts with NEF by two hybrid (View interaction)
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senior authors.1. Introduction
Alix [ALG-2 (apoptosis-linked gene 2)-interacting protein X] is
an adapter protein involved in normal and pathological cellular
processes, including regulation of apoptosis, cytoskeletal dynam-
ics, cell surface receptor internalization, endosomal sorting pro-
cesses and virus budding from infected cell membranes [1–7].
These diverse functions appear to involve binding to various viral
and cellular proteins (for review, refer to [8]), including kinaseslsevier B.V. All rights reserved.
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ability of Alix to regulate cell surface receptor internalization and
cell adhesion [9].
Crystal structures have revealed that human Alix is composed
of three domains involved in multiple and diverse protein interac-
tions: the N-terminal Bro1 domain (residues 1–358), that binds to
ESCRT-I/III proteins [7,10], a central V domain (residues 362–702)
that is formed by two three-helix bundles disposed in a ‘‘V’’ shape;
and a C-terminal PRR (proline-rich region; residues 703–868) that
is not present in the available crystal structures, that serves as a
docking site for a number of proteins, including TSG101 and Src-
homology (SH)3 domain-containing proteins [10,11].
We previously identiﬁed Alix as a novel hematopoietic cell ki-
nase (Hck) SH3-binding protein by yeast two-hybrid screening
using the SH3 domains of Src family kinases (SFKs) [12]. Identiﬁca-
tion of Src-related Hck as a novel Alix binding partner was partic-
ularly relevant given the implication of Hck in similar cellular and
pathological functions, including adhesion, actin polymerization,
and HIV-1 infection (for review, see [13]). We demonstrated that
Alix binds to and activates Hck, and delineated the proline-rich
(PxxP) motif of the Alix PRR involved in binding to Hck-SH3. In
the same study, we demonstrated that Alix residues outside of
the PxxP motif enhanced afﬁnity and also possibly speciﬁcity for
Hck-SH3, which was reminiscent of the tertiary binding mode used
by the viral protein Nef-HIV-1 [14–16]. Interactions outside the
PxxP motif are thought to enhance afﬁnity and speciﬁcity for
SH3 domains (for review, refer to [17]) as demonstrated by the
high afﬁnity binding of the viral Nef protein to Hck SH3 domain
which implicates a well-deﬁned hydrophobic pocket formed by
two a-helices of Nef [14]. In addition to the canonical PXXP motif,
this pocket provides a three-dimensional ‘tertiary’ binding surface
which has not been described so far for cellular proteins. We thus
investigated in the current research, on the mode of binding of Alix
to Hck-SH3 domain by combining ITC, NMR, SAXS and molecular
modeling experiments and compared it to that of HIV-1 Nef.
2. Materials and methods
2.1. DNA construction
Human Alix recombinant construct (ALIXV+PRR) consisting of
residues 362–760 was prepared as previously described [12].
Wild-type Fyn-SH3 (Fyn(WT)-SH3) and Fyn(R96I)-SH3 sequences
were ampliﬁed from pGEX-Fyn(WT) and pGEX-Fyn(R96I) plasmid
constructs, respectively, and cloned into pET42a expression vectors
using NdeI and XhoI restriction sites. Each construct was veriﬁed
by DNA sequencing.
2.2. Yeast two-hybrid (Y2H)screen
Two independent yeast two-hybrid (Y2H) were performed in
parallel, using the human Hck- or Fyn(R96I)-SH3 domain as a bait.
Y2H system is based on the protocol described by Walhout et al.
[18] as described in Materials and Methods in the Supporting
Information.
2.3. Protein expression
Human Alix recombinant construct (ALIXV+PRR) was expressed
with an N-terminal His6-Smt3 fusion tag in Escherichia coli strain
BL21 (DE3). The different SH3 recombinant proteins (Fyn(WT)-SH3,
Fyn(R96I)-HS3, and Hck-SH3) were similarly expressed as 6xHis
C-terminal fusion proteins in E. coli BL21 (DE3). The different
recombinant proteins (ALIXV+PRR and SH3 protein) were expressed
and puriﬁed as described in Materials and Methods in the
Supporting Information.2.4. Isothermal titration calorimetry (ITC)
ITC was used to evaluate the thermodynamics parameters of
the binding between ALIXPI peptide and Fyn(WT)-SH3 or Fyn(R96I)-
SH3. Titrations were carried out at 25 C on a MicroCal ITC200
microcalorimeter (GE Healthcare, Piscataway, NJ). Experiments
and data analysis were performed as described in Materials and
Methods in the Supporting Information.
2.5. NMR spectroscopy
To further elucidate the interaction mode between the SH3 do-
mains and ALIXV+PRR, 1H–15N heteronuclear single quantum coher-
ence (HSQC) experiments were performed as described in
Materials and Methods in the Supporting Information.
2.6. Small-angle X-ray scattering (SAXS) analysis
Data used for the SAXS analysis of the complex between
Fyn(R96I) and ALIXV+PRR were collected at the SWING beamline of
the SOLEIL synchrotron in Paris, France, as described in more
details in Materials and Methods in the Supporting Information.
2.7. Peptide docking studies
Docking of Alix peptide onto Fyn(R96I)-SH3 and Fyn(WT)-SH3 mu-
tants was performed using the high-resolution modeling protocol
provided by FlexPepDock [19]. The Fyn Fyn(R96I)-SH3:HIV-1 Nef
crystal structure (PDB ID 1EFN [14]) was used as a template for
Fyn(R96I)-SH3. Fyn(WT)-SH3 was obtained by replacing I96 with an
arginine (in its most common rotamer). The initial Alix peptide
structure was obtained by computationally mutating and extend-
ing the Nef PXXP motif from the pdb template. FlexPepDock was
set up to produce 300 low resolution and 300 high resolution
structures. Produced models reached peptide backbone r.m.s.d. of
more than 10 Å compared to the initial peptide structure, showing
that the ﬂexible docking procedure was not only exploring local
minima.
3. Results and discussion
3.1. Isoleucine 92 from the Haemopoietic cell kinase RT-loop is
involved in the speciﬁc recognition of ALIXV+PRR
The so-called ‘‘tertiary’’ mode of recognition used by HIV-1 Nef
to selectively target SH3 domains is provided by the folded core
domain of the protein [14,16]. In addition to binding mediated
by the PPII helix, an isoleucine residue from the RT loop of the
Hck SH3 domain (I92) inserts into a well-deﬁned hydrophobic
pocket formed by two a-helices of Nef. The corresponding residue
in Fyn SH3 RT loop is an arginine (R96) which leads to a low afﬁnity
binding to Nef (Kd > 20 lM), whereas its substitution by an isoleu-
cine (R96I) converts the Fyn SH3 domain from a low to a high afﬁn-
ity (Kd  0.4 lM) binding partner for Nef [15]. This selective mode
of recognition mediated by HIV-1 Nef was reproduced in a yeast
two hybrid assay, as shown in Supplementary Fig. S1A. Co-trans-
formation of cells with Nef resulted in b-Galactosidase production
and yeast outgrowth on media lacking uracil for Hck-SH3 and
Fyn(R96I)-SH3 as baits, but not for Fyn(WT)-SH3. These results were
conﬁrmed using the lacz and his3 reporters for Nef:Hck-SH3 and
Nef:Fyn(WT)-SH3 (because Fyn(R96I)-SH3 alone was able to transac-
tivate the lacz and his3, Fyn(R96I)-SH3 could not be used with these
reporter systems). In contrast to HIV-1 Nef, the Src-associated in
mitosis 68 kDa (SAM68) protein interacted with comparable
strength with every SH3 domain, indicating that the architecture
Fig. 1. (A, B) Experimental ITC binding curves for the interaction between ALIXPI and (A) Fyn(wt)-SH3, (B) Fyn(R96I)-SH3. Top panel: Raw ITC data from an experiment. Bottom
panel: Non-linear least-squares ﬁt of the data from the top panel after blank subtraction.
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of the RT-loop amino acid position 96 (negative control).
Next, we analyzed the interaction between these SH3 domains
and an Alix fragment encoded by one Alix clone, called IIIA9, ob-
tained in a yeast two hybrid screening using the Hck SH3 domain
as bait [12]. This Alix fragment contained the Hck-interacting pro-
line-rich region (PRR) as well as part of the Alix V domain (align-
ment details in Supplementary Fig. S1C), suggesting that these
two regions of the Alix V domain contribute to Hck SH3 binding,
which was reminiscent of the Nef binding mode of action (Supple-
mentary Fig. S1B).
To conﬁrm the ‘‘Nef-like’’ binding selectivity for the RT-loop po-
sition 92 in vitro, we carried out GST pull-down experiments fol-
lowed by SDS–PAGE and Coomassie blue staining. These
experiments illustrate the binding of an Alix fragment encoding
for the V domain and the SH3-binding PRR motif (AlixV+PRR) to
Hck-SH3-GST and Fyn(R96I)-SH3-GST but not to Fyn(WT)-SH3-GST
(Supplementary Fig. S2). Thus, the recombinant ALIXV+PRR could
differentiate SH3 domains according to their amino acids at posi-
tion 92 (or 96 for Fyn), displaying a ‘‘Nef-like’’ selectivity in vitro.
3.2. Molecular recognition mode does not involve a 3D ﬁngerprint but
rather demonstrates an extended linear pattern
Next, we asked whether the ALIXV+PRR-SH3 binding site was
demonstrating a structurally similar binding site to the one ob-
served for HIV-1 Nef protein. For Nef, the tertiary SH3 recognition
binding site is formed by the Nef PRR and part of the folded Nef
core domain [14,16]. In contrast, sequence analysis and secondary
structure prediction indicates that the Alix PRR is located within an
unstructured region, 35 residues away from the folded V domain
(Supplementary Fig. S3). The location of the Alix PRR in anunstructured region is consistent with our previous SAXS data for
apo-ALIXV+PRR [12]. We, and others, previously published ITC
experiments indicating that the afﬁnity and thermodynamic
parameters of the Nef/Hck-SH3 interaction were dramatically dif-
ferent from those of the interaction between Hck-SH3 and the
Nef PRR peptide [15,20]. Similarly, previous ITC experiments for
the Alix/Hck-SH3 complex demonstrated that a peptide containing
the minimal Alix PxxP consensus motif (ALIXPI, residues 737–760)
did not fully reproduce the binding characteristics of ALIXV+PRR to-
ward Hck-SH3; however, inclusion of residues N-terminal to the
PxxP consensus motif in the peptide sequence almost completely
restored the binding characteristics of ALIXV+PRR [12]. In the pres-
ent study, we demonstrate that the isolated peptide ALIXPI is also
capable of distinguishing between Fyn(WT)-SH3 (Kd = 160 ± 30 lM)
and Fyn(R96I)-SH3 (Kd = 54 ± 10 lM), and that ALIXPI binds to each
SH3 domain with Kd’s similar to those observed with ALIXV+PRR
(please refer to Fig. 1A and B for the peptide ALIXPI in complex with
Fyn(WT)-SH3 or Fyn(R96I)-SH3 experiments, to compare with [12] for
the peptide ALIXPI or ALIXV+PRR in complex with Hck-SH3 experi-
ment). These results suggest that if a tertiary ‘Nef-like’ binding
occurs, its thermodynamic ﬁngerprint is weak. Also, our previous
NMR studies failed to show a signiﬁcant difference between the
imprints of ALIXV+PRR and the Alix PRR peptide on Hck-SH3, and
hence they failed to reveal a clear indicator of a tertiary 3D binding
site [12]. Therefore, we used NMR to investigate whether the im-
print of ALIXV+PRR on the different SH3 domains varies with their
origin or afﬁnity.
NMR HSQC experiments with 15N-labelled Hck-SH3, Fyn(WT)-
SH3, and Fyn(R96I)-SH3 in the presence of 1 equiv. of unlabelled
ALIXV+PRR showed that the chemical shifts induced by ALIXV+PRR
mapped to almost the same residues on the surfaces of all SH3 do-
mains, including the low-afﬁnity Fyn(WT)-SH3 domain (Fig. 2A–C).
Fig. 2. Mapping of the SH3 domains’ atomic recognition surfaces in the presence of ALIXV+PRR by heteronuclear NMR. (A–C) Left: SH3 residues’ chemical shifts observed for (A)
Hck-SH3, (B) Fyn(R96I)-SH3, and (C) Fyn(WT)-SH3 in the presence of 1 equiv. of ALIXV+PRR, shown as histograms. The relative variations of 1H and 15N were calculated according
to Grzesiek et al. [22]. Center: Ribbon representation of the different SH3 domains with important interacting residues in yellow for (A) Hck-SH3, (B) Fyn(R96I)-SH3, and (C)
Fyn(WT)-SH3 (PDB entries 1BU1, 1EFN, and 1AVZ, respectively). Right: Corresponding chemical shifts of the SH3 proteins in the presence of 1 equiv. of ALIXV+PRR, shown as a
surface representation onto the SH3 domain structures. Small chemical shift variations are represented in yellow, larger shifts in orange, and the largest in red.
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tributed over four regions of the SH3 domain—the RT loop, the nSrc
loop, the 310 helix, and the canonical hydrophobic grooves
(Fig. 2A)—in agreement with the results of our previous study of
ALIXV+PRR binding to Hck-SH3 [12]. Of note, the intensity of the
chemical shift increased remarkably, as expected, with the Kd ob-
served (using strictly the same, 1 equiv. amount of ALIXV+PRR in
all experiments). Although the imprints are similar globally, subtle
differences can be observed in the surface area of the residues in-
volved in the recognition process; for example, the nSrc loop seems
to be more involved in the Hck-SH3–ALIXV+PRR interaction than in
the Fyn(R96I)-SH3–ALIXV+PRR interaction (Fig. 2A–C). Nonetheless,
the overall interaction mode is similar enough for all SH3 proteins
to indicate a structurally similar engagement of all three SH3 do-
mains by ALIXV+PRR. Also, the extent of the binding surface on
SH3 domains is compatible with an ALIXV+PRR binding mode that
has a linear ‘‘peptide-like’’ interaction rather than a ‘Nef-like’ 3D
interaction.
3.3. Molecular model of the SH3-ALIXV+PRR complex
To corroborate that the PRR in ALIXV+PRR does not join the V
domain to form a ‘Nef-like’ tertiary SH3 binding site upon SH3
engagement, we used SAXS. Ensemble Optimization Method
(EOM) reconstructions showed that the PRR-bound Fyn(R96I)-SH3was highly ﬂexible and had a large, variable distance from the V
domain core (Fig. 3A and B). The maximum diameter (Dm) calcu-
lated from the SAXS data for Fyn(R96I)-SH3-bound ALIXV+PRR
(Dm = 190 ± 10 Å) was the same as the Dm value we measured pre-
viously for apo-ALIXV+PRR [12]. These results argue against a model
in which the SH3 binding motif in the ﬂexible region C-terminal to
the Alix V domain folds back onto the V domain to form a com-
bined tertiary SH3 site.
Together, our data indicate that Alix achieves a ‘Nef-like’ RT-
loop selection through a linear ‘‘peptide-like’’ binding mode rather
than through a ‘Nef-like’ tertiary SH3 recognition mode. Hence, the
observed differences in the Y2H and Kd, especially between
Fyn(WT)-SH3 and Fyn(R96I)-SH3, must be explained by differences
in the interaction between the Alix PRR sequence and the SH3 RT
loops. All attempts to crystallize Fyn(R96I)-SH3 in a complex with
Alix PRR failed, because all crystals packing involve homologous
interactions between PxxP-motif binding sites of the SH3 domain.
We therefore used the high-resolution docking and reﬁnement
protocol FlexPepDock [19] to model SH3–peptide complexes. Flex-
PepDock is implemented within the ROSETTA framework, which
has proven its high accuracy in several landmark modeling suc-
cesses. The obtained Fyn(R96I)-SH3/ALIXPI and Fyn(WT)-SH3/ALIXPI
structures provide a possible explanation for how a linear se-
quence can distinguish between R96 and I96. These structures
show that in addition to the canonical interaction between Fyn
Fig. 3. SAXS model of ALIXV+PRR complexed to Fyn(R96I)-SH3. (A) Fit of EOM SAXS ensemble model (red) to data (black). (B) Three representative structural models taken from
an ensemble of 15 structures produced by EOM on the basis of SAXS data, superimposed on their Alix V domain (black ribbon). ALIXV+PRR-bound Fyn(R96I)-SH3 (represented as
secondary structures) and ﬂexible residues (represented as spheres) linking the Alix PRR to the V domain have a different color for each model. (C) Alix peptide/Fyn(R96I)-SH3
(top) and Alix peptide/Fyn(WT)-SH3 (bottom) 3D interaction models obtained from Flexpepdock. SH3 domains are oriented as in Fig. 2. SH3 surfaces are colored according to
blue, positively charged atoms; red, negatively charged atoms; green, hydrophobic atoms; salmon, polar oxygens; light blue, polar nitrogens; yellow, sulfur. The Alix peptide
is shown as a stick model.
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able hydrophobic interactions with ALIXPI prolines 754, 758–759
(Fig. 3C). These favorable proximity of hydrophobic residues is
not possible with R96 of Fyn(WT)-SH3. In addition, the proximity
of the positive charge of R96 may also decrease the strength of
an interaction between Fyn E94 and ALIXPI K751. E94 is conserved
in Hck-SH3, and FlexPepDock analysis suggests that this E94–ALIX-
PI K751 interaction is conserved in Hck (data not shown). Our dock-
ing analysis also provides a possible explanation for our previous
observation that the minimal Alix PxxP consensus does not fully
reproduce the binding of ALIXV+PRR [12], by suggesting that Alix
M747 (which was not included in the minimal Alix PxxP peptide)
engages a hydrophobic interaction with an apolar pocket formed
by Fyn-SH3 L90 and Y91.
4. Conclusion
Our results indicate that ALIX achieves a ‘Nef-like’ RT-loop
selection through an extended linear ‘‘peptide-like’’ binding mode
rather than through a ‘Nef-like’ tertiary SH3 recognition mode. Our
binding studies and computational modeling analysis suggest a
molecular basis for how the extended linear interaction of ALIXwith Hck-SH3 is capable of reproducing the 3D ‘tertiary’ binding
mode of HIV-1 Nef without a 3D organization. Together with the
observation that linear SH3-binding motifs can bind to SH3
domains with similar afﬁnities than does HIV-1 Nef [21], this opens
the question why Nef uses a costly three-dimensional framework
for SH3 binding if a much simpler linear recognition motif achieves
the same afﬁnity and speciﬁcity.
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